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Adherent–invasive Escherichia coli (AIEC) have been implicated in the aetiology of Crohn’s
disease (CD), a chronic inflammatory bowel condition. It has been proposed that AIEC-infected
macrophages produce high levels of pro-inflammatory cytokines thus contributing to the
inflammation observed in CD. AIEC can replicate in macrophages and we wanted to determine if
bacterial replication was linked to the high level of cytokine production associated with AIEC-
infected macrophages. Therefore, we undertook a genetic analysis of the metabolic requirements
for AIEC replication in the macrophage and we show that AIEC replication in this niche is
dependent on bacterial glycolysis. In addition, our analyses indicate that AIEC have access to a
wide range of nutrients in the macrophage, although the levels of purines and pyrimidines do
appear to be limiting. Finally, we show that the macrophage response to AIEC infection is
indistinguishable from the response to the non-replicating glycolysis mutant (DpfkAB) and a non-
pathogenic strain of E. coli, MG1655. Therefore, AIEC does not appear to subvert the normal
macrophage response to E. coli during infection.
INTRODUCTION
Crohn’s disease (CD) is an inflammatory bowel disease that
affects millions of people around the world, particularly in
North America and Europe (Molodecky et al., 2012). The
disease is characterized by chronic inflammation anywhere
in the gastrointestinal tract (from the mouth to the anus) but
is most associated with lesions in the ileum and colon of
patients. There is a genetic component to CD and recent
genome-wide association studies have identified polymor-
phisms in a number of host genes that are strongly associated
with CD, e.g. NOD2, ATG16L1 and IRGM (Khor et al.,
2011). However the relatively rapid, and recent, increase in
the incidence of CD also points to a significant role for envi-
ronmental factors in the aetiology of this disease. In recent
years, a group of Escherichia coli called adherent–invasive
Escherichia coli (AIEC) have been found to be present in the
guts of CD patients at a higher frequency than in healthy
subjects, leading to the suggestion that AIEC may be involved
in initiating and/or maintaining the inflammation associated
with CD (Negroni et al., 2012; Rhodes, 2007; Rolhion & Dar-
feuille-Michaud, 2007). AIEC have also been found associ-
ated with CD-like diseases in other mammals, e.g.
granulomatous colitis in boxer dogs (Simpson et al., 2006).
AIEC can be distinguished from other strains of E. coli by
the presence of two phenotypes. Firstly, AIEC have the abil-
ity to invade epithelial cells, and secondly, AIEC have the
ability to replicate in a variety of macrophages, including
primary cells such as human monocyte-derived macro-
phages (Boudeau et al., 1999; Glasser et al., 2001; Martin
et al., 2004; Subramanian et al., 2008). Molecular studies
using the AIEC strain LF82 have identified factors that are
important for each of these phenotypic properties. For
example, invasion of epithelial cells by LF82 requires the
expression of both Type 1 fimbriae and flagella (Barnich
et al., 2003; Boudeau et al., 2001). It has also been previ-
ously shown that LF82 requires acidification of the phago-
some to replicate in the macrophage and it is not
surprising, therefore, that the htrA (degP) and dsbA genes,
both encoding proteins required for the bacteria to survive
stress, are required for replication in this niche (Bringer
Abbreviations: AIEC, adherent–invasive Escherichia coli; CD, Crohn’s
disease; Kn, kanamycin; SCV, Salmonella-containing vacuole.
Nine supplementary figures and a supplementary table are available with
the online Supplementary Material.
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et al., 2005, 2007, 2012). However, all of the genes so far
implicated in the AIEC phenotype are also found in non-
AIEC strains of E. coli. Indeed recent genomic studies have
failed to identify any AIEC-specific genes that can ade-
quately explain the ability of this group of E. coli to invade
epithelial cells and replicate in macrophages (Clarke et al.,
2011; Krause et al., 2011; Miquel et al., 2010; Nash et al.,
2010; Vejborg et al., 2011; Zhang et al., 2015). Nonetheless
epidemiological evidence does suggest that E. coli are
enriched in the guts and macrophages of the lamina propria
of CD patients compared to healthy controls (Conte et al.,
2014; Darfeuille-Michaud et al., 2004; de Souza et al., 2012;
Elliott et al., 2015; Martinez-Medina et al., 2009).
We wanted to identify the metabolic requirements of AIEC
replication in the macrophage. We also wanted to deter-
mine whether AIEC replication was achieved by, or resulted
in, any alteration to the normal macrophage response to
infection. In this study we confirm that our strain of AIEC
replicates within acidified vacuoles in the macrophage.
Moreover we show, using genetics, that AIEC replication
requires glycolysis and is largely independent of the TCA
cycle, the glyoxylate pathway, the pentose-phosphate path-
way and gluconeogenesis. Furthermore our data reveal that
AIEC replication in the macrophage does have a require-
ment for de novo nucleotide biosynthesis. Finally we report
that the response of the macrophage to infection with wild-
type AIEC, the non-replicating glycolysis mutant or the
non-pathogenic strain MG1655 appears to be identical, sug-
gesting that AIEC do not subvert the normal macrophage
response to infection in order to establish their replicative
niche.
METHODS
Bacterial strains, plasmids and cell lines. The strain of AIEC used
in this study was HM605, isolated from the colon of a patient with CD
(Martin et al., 2004). E. coli K-12 strain MG1655 was used as a non-
pathogenic control. All bacteria were routinely cultured in LB broth or
M9 minimal medium [supplemented with 0.2% (w/v) glucose unless
otherwise indicated] at 37

C with or without shaking, as indicated.
Antibiotics were added as required at the following concentrations:
ampicillin (Amp) 100 µg ml 1, kanamycin (Kn) 50µg ml 1, and chlor-
amphenicol (Cm) 25 µg ml 1. Murine macrophage-like J774A.1 cells
were purchased from ATCC and were maintained in a 5% (v/v) CO2
atmosphere in Dulbecco’s Modified Eagle Medium (DMEM), high glu-
cose, Glutamax (Gibco) supplemented with 10% (v/v) FBS, 100 U ml 1
penicillin and 100 µg ml 1 streptomycin.
Gentamicin protection assays. To measure the intramacrophagic
replication of HM605 we used a gentamicin protection assay
described previously (Subramanian et al., 2008). Approximately
4105 J774A.1 cells were seeded into each of the wells of a 24-well
tissue culture plate. After 20h cells were infected, at an m.o.i.of 10
bacteria per cell, with the appropriate bacteria which had been cul-
tured overnight at 37

C in LB broth without shaking. Bacterial cul-
tures were centrifuged and cell pellets were re-suspended in DMEM
to the appropriate cell density before infecting the macrophages. After
2 h at 37

C the medium was removed and replaced with an equal
volume of DMEM containing gentamicin (100µg ml 1), to kill any
extracellular bacteria. After incubation for 1 h, the cells were either
washed three times with PBS and lysed with 500 µl 1 of 1% (v/v)
Triton X-100 to release the intracellular bacteria (this is equivalent to
T0) or fresh DMEM with gentamicin was added for further incuba-
tion for the appropriate time. Released bacteria were enumerated by
plating on LB agar containing ampicillin because HM605 is naturally
resistant to this antibiotic.
Lysotracker Red-DND99 staining. J774A.1 were seeded on no. 1.5
glass coverslips in 24-well plates (Corning) 20–24h before infection.
GFP-tagged HM605 and MG1655 were added to cells at an m.o.i. of 10;
plates were then centrifuged at 300 g for 5min to synchronize infections,
followed by incubation at 37

C/5% CO2 in a humidified incubator for
20min. Cells were then washed twice with warm 1 PBS and resus-
pended in growth medium supplemented with 50µg ml 1 gentamicin.
Cells were incubated as before for a further 30min and this was taken as
time T0. Cells were washed with 1 PBS and 250 nM Lysotracker Red-
DND99 (Molecular Probes) diluted in gentamicin-supplemented cul-
ture medium was added to sample wells for 30min. Cells were then
fixed in 4% paraformaldehyde (pH7.4) for 15min at room temperature
in the dark and washed extensively. Coverslips were then mounted on
microscope slides with DAKO mounting medium (DAKO) and incu-
bated at room temperature in the dark overnight. Samples were visual-
ized with a Zeiss LSM 5 laser scanning confocal microscope using a
Plan-Apochromat 63/1.40 oil DIC M27 lens. For GFP, samples were
excited with an argon laser at 488 nm and emitted light was acquired
using a bandpass emission filter of 505–550 nm. For Lysotracker visuali-
zation, samples were excited with laser light at 543 nm and emitted light
acquired through a bandpass filter at 560–615 nm. Sample images were
taken using Zen 2008 SP2 software (Zeiss). Cells were scored as positive
for co-localization if green bacteria-containing vacuoles overlapped with
red Lysotracker vesicles. Slides were stored at 4

C in the dark until ana-
lysed and all analysis was performed within 1 week. All experiments
were carried out in triplicate.
Transposon mutant library. A transposon mutant library of HM605
was constructed using the EZ-Tn5 <KAN-2> insertion kit, following
the manufacturer’s instructions (Epicentre). After screening, transpo-
son insertion sites were determined by amplifying the genomic region
flanking the transposon using two rounds of arbitrarily primed PCR. In
the first PCR (PCR 1), the random primers ARB1 (5¢-GGCCACGCG
TCGACTAGTTACNNNNNNNNNNGATAT-3¢) and ARB6 (5¢-
GGCCACGCGTCGACTAGTACNNNNNNNNNNACGCC-3¢) were
paired with an external Tn5 specific primer, Tn5ext (5’-CCTGA
TTGCCCGACATTATCGCG-3¢). The products from PCR 1 were puri-
fied and used as a template for the second PCR (PCR 2), using the
internal Tn5 specific primer, Tn5int (5¢-GAATATGGCTCATAA-
CACCC-3¢) and the random primer ARB2 (5¢-GGCCACGCGTCGAC
TTAGTTAC-3¢). PCRs were carried out using the Velocity PCR kit
(Bioline) and PCR products were purified using the QIAquick PCR
purification kit (QIAGEN). After PCR 2, the amplicons were purified
and sequenced, using Tn5int as the primer, by GATC Biotech (Ger-
many). DNA sequences were then compared to the HM605 genome
sequence in order to determine the exact location of the transposon
(Clarke et al., 2011).
Construction of metabolic mutants by P1 transduction. Mutants
were constructed by P1 transduction using strains from the KEIO library
as donors. The KEIO library is a library of single gene knockouts in all
non-essential genes in E. coli K-12 strain BW25113 (Baba et al., 2006).
Each gene is deleted and replaced with a Kn resistance cassette flanked
by FLP recognition target (FRT) sites. All HM605 mutants constructed
in this way were phenotypically tested for veracity (see text for details).
For the construction of the DpfkAB double mutant, the Kn resistance
cassette was excised from the DpfkA :: Kn mutant using a yeast FLP
recombinase expressed from pFLP3 (Choi et al., 2005). The DpfkB :: Kn
allele was then transduced into the DpfkA background, resulting in
DpfkA DpfkB :: Kn (represented as DpfkAB for simplicity).
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Measuring cytokine production. The production of cytokines was
measured using Meso Scale Discovery technology, according to the
manufacturer’s instructions (MSD Meso Scale Discovery). Macrophages
were infected with the appropriate bacteria (as described) and cell cul-
ture supernatants were taken at the indicated times for analysis. For
detection of cytokines 25µl 1 of each supernatant was dispensed into
separate wells of the MSD plate. The plate was then sealed and incubated
for 2 h with vigorous shaking at room temperature before 25µl 1 of the
1 Detection Antibody Solution was dispensed into each well. The plate
was again sealed and incubated for 2 h with vigorous shaking at room
temperature. Finally, each well was washed three times with PBS
+ 0.05% (v/v) Tween 20 followed by the addition of 150 µl 1 2 Read
Buffer T to each well of the plate. The plate was then immediately ana-
lysed using the SECTOR Imager and cytokine concentrations were
determined using a standard curve.
RNA isolation and microarray analysis. J774A.1 macrophages were
seeded in 6-well tissue culture plates (Sarstedt) at a density of 1106
cells and infected at an m.o.i. of 10 with the appropriate bacteria, as
described above. At 6 h post-gentamicin treatment, the macrophages
were washed with PBS, scraped from the well surface and pelleted. Cells
were lysed using RLT lysis buffer (QIAGEN) and total RNA was isolated
using RNeasy Mini kit (QIAGEN) as per manufacturer’s instructions.
Before further analysis the quality and purity of the RNA was analysed
using a Nanodrop spectrophotometer. Total RNA was then shipped to
Beckman Coulter for microarray analysis using their SurePrint G3
Mouse GE 860K microarrays. Each array contains oligonucleotide
probes for 39 340 murine Entrez gene RNAs and 16 251 lincRNAs, and
hybridizations were carried out in triplicate using independent total
RNA preparations. For analysis, each array was corrected for back-
ground, quantile normalized and log-transformed (log2) using Biocon-
ductor packages in the R software environment (Gentleman et al.,
2004). Differential expression was carried out using functions from the
LIMMA package in Bioconductor (Smyth, 2004). P values were adjusted
to correct for multiple testing by using the Benjamini–Hochberg
method (Benjamini & Hochberg, 1995).
Metabolomics. J774A.1 macrophages were infected with either WT,
the DpfkABmutant or the DpyrFmutant at an m.o.i. of 10, as previously
described, and total cell lysates were collected 6 h post-gentamicin treat-
ment. An uninfected macrophage control was also included and all sam-
ples were prepared in triplicate. Macrophages (approx. 8107 cells per
sample) were rapidly cooled by submersion in a dry ice/ethanol bath. All
subsequent steps were carried out at 4

C. Cells were collected by centri-
fugation at 1000 g for 10min and supernatant was discarded. The cell
pellet was resuspended in cold medium and transferred to an Eppendorf
tube. The cells were pelleted by centrifugation at 2500 g for 5min and
the supernatant was completely removed. The cell pellet was resus-
pended in 200 µl chloroform/methanol/water (1 : 3 : 1) at 4

C and cells
were lysed by vortexing at 4

C. The lysate was centrifuged at 13000 g for
3min to remove debris and the supernatant (approx. 180 µl) was
retained and stored at  80

C until further analysis. Samples were ana-
lysed by hydrophilic interaction liquid chromatography–mass spectrom-
etry (UltiMate 3000 RSLC; Thermo Fisher) with a 1504.6mm ZIC-
pHILIC column running at 300 µl min 1 and Orbitrap Exactive
(Thermo Fisher) analysis. Buffers consisted of (A) 20mM ammonium
carbonate in H2O, and (B) acetonitrile. The gradient ran from 20% A,
80% B to 80% A, 20% B in 15min, followed by a wash at 95% A, 5%
B for 4min, and equilibration at 20% A, 80% B for 6min. Raw mass
spectrometry data were processed using a standard pipeline, consisting
of XCMS (for peak picking), MzMatch (for filtering and grouping) and
IDEOM (for further filtering, post-processing and identification) (Creek
et al., 2012; Scheltema et al., 2011; Smith et al., 2006). Metabolites listed
as identified were validated against a panel of unambiguous standards by
mass and retention time and may be designated HRMSa
1RTa (Sumner
et al., 2014). Additional putative identifications were assigned by mass
and predicted retention time and are designated HRMSlib
1 (Creek et al.,
2011). Means and SEM errors of the mean were generated for all groups
of picked peaks and the resulting data were uploaded to KEGG for path-
way analysis.
Statistical analysis. All statistical analysis was performed using
GraphPad Prism v6.0e for Mac OS X software. All experiments were
performed at least three times and the data were tested for statistical sig-
nificance using Student’s t-test (for direct comparisons) or one-way
ANOVA with Dunnett’s post-test correction for multiple comparisons.
RESULTS
Intramacrophagic replication of AIEC strain
HM605 occurs in an acidified phagosome
AIEC are characterized by their ability to replicate in mac-
rophages, including the J774A.1 murine macrophage-like
cell line. In this study we used a strain of AIEC, called
HM605, isolated from a biopsy taken from the colon of a
patient with CD (Martin et al., 2004). Using a gentamicin
protection assay we showed that, over a 6 h period, HM605
replicated inside the J774A.1 macrophage whilst a non-
pathogenic strain of E. coli, MG1655, did not exhibit any
replication (Fig. 1a). Moreover, using bacterial strains that
were tagged with GFP under the control of a constitutive
promoter, we could clearly see an increase over time in the
number of HM605 cells/macrophage compared to MG1655
(Fig. 1b, c). Using transmission electron microscopy we
showed that, inside the macrophage, HM605 cells were
located within vacuoles (Fig. S1, available in the online Sup-
plementary Material). Using Lysotracker Red-DND99, we
could show that, 6 h post-gentamicin addition, >60% of
HM605 cells co-localized with acidified vacuoles
(Fig. 1b, d). Interestingly this is similar to the level of co-
localization that was observed for MG1655, the non-patho-
genic strain of E. coli, suggesting that HM605 does not
subvert the normal phagocytic response of macrophages
(Fig. 1b, d). Finally, addition of bafilomycin A1 (an inhibi-
tor of the phagosomal ATPase proton pump) to infected
macrophages prevented HM605 replication, showing that
acidification of the phagosome is required for AIEC replica-
tion (Fig. 1e). Importantly bafilomycin A did not affect bac-
terial growth during culturing in growth medium (Fig. S2).
HM605 replication was also blocked when NH4Cl [an
inhibitor of phagosome–lysosome fusion (Hart & Young,
1991)] was added to the macrophages (Fig. S3). Our data
are in good agreement with previous work using the proto-
typical AIEC strain LF82, where it was shown that bacterial
replication requires the acidification of phagosomes
(Bringer et al., 2006). Therefore, we conclude that HM605
replicates within acidified vacuoles, most likely phago-
somes, in J774A.1 macrophages.
Glycolysis is required for replication of HM605 in
the macrophage
HM605 exhibited rapid growth within the phagosome, sug-
gesting that the bacteria have ready access to nutrients (see
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Fig. 1). We were interested in characterizing the metabolic
pathways required by HM605 during replication in this
niche. To do this we constructed mutations in genes
involved in the major metabolic pathways of glycolysis
(DpfkAB), the TCA cycle (Dicd), the glyoxylate pathway
(DaceA), the Entner–Doudoroff pathway (Deda), the pen-
tose-phosphate pathway (Dgnd) and gluconeogenesis
(Dfbp). The disruption in the expected pathway was verified
by growing the mutants in M9 minimal medium supple-
mented with glucose, glycerol, acetate or gluconate as the
sole carbon source (see Figs S4 and S5). Although a null
mutation in gnd does not have a significant effect on the
growth of E. coli it has been shown that a Dgnd mutation
does block the pentose-phosphate pathway and this results
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Fig. 1. HM605 replication in J774A.1 macrophages. (a) J774A.1 cells were infected with HM605 or MG1655 at an m.o.
i. of 10 and intracellular bacterial numbers were assayed at the indicated times using the gentamicin protection assay. The
fold-replication was calculated by dividing the number of bacteria inside the macrophage at T6 by the number of bacteria at T0.
(b) J774A.1 macrophages were infected with GFP-tagged HM605 or GFP-tagged MG1655. Macrophages were stained with
Lysotracker Red-DND99 (as described in Methods) and samples were analysed using a Zeiss LSM 5 confocal microscope.
Images are representative of three independent biological replicates. Bars, 5 µm. (c) Bacterial number per macrophage as
measured by directly counting the number of GFP-labelled bacteria per macrophage (n=100) at the time indicated. (d) Per-
centage of bacteria co-localizing with Lysotracker Red-DND99 at T0 and T6. Macrophages were infected and cells fixed and
stained at the indicated times. At least 100 bacteria-containing macrophages were counted per replicate and data shown are
the mean of three independent replicates. (e) J774A.1 macrophages were infected with HM605 and treated with 50 nM bafilo-
mycin A (BafA1) to prevent phagosome acidification. The numbers of intracellular bacteria were measured at T6 and are pre-
sented as percentage c.f.u. ml 1 relative to untreated HM605-infected macrophages. All experiments were carried out in
triplicate and the error bars represent SD. Statistical significance was determined using the Student t-test; ***P<0.0005,
*P<0.05.
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in a significant rerouting of carbon flux in E. coli (Zhao
et al., 2004). Each of the mutants (DpfkAB, Dicd, DaceA,
Deda, Dgnd and Dfbp) was then checked for its ability to
replicate in J774A.1 macrophages relative to HM605. Inter-
estingly, the DpfkAB mutant showed the most significant
defect in its ability to grow in the macrophage (6.1±1.1%
of wild-type levels; P=0.0026) suggesting an important role
for glycolysis during the in vivo replication of HM605
(Fig. 2). Importantly replication was restored when the
DpfkAB mutant was complemented by the expression of
either pfkA or pfkB from a plasmid (Fig. 2b). The pfkA- or
pfkB-expressing plasmids did complement the growth of
the DpfkAB mutant on glucose, suggesting that the partial
complementation observed in the macrophage is likely due
to expression levels and/or plasmid retention during infec-
tion (Fig. S6). There also appears to be a role, albeit more
limited, for the pentose-phosphate pathway during in vivo
replication as the Dgnd mutant showed a significant reduc-
tion in growth in the macrophage relative to HM605 (43 ±
17.1% of wild-type levels; P=0.0024) (Fig. 2). The remain-
ing mutants grew as well as HM605 in the macrophage, sug-
gesting no significant requirement for the TCA cycle,
gluconeogenesis, the glyoxylate pathway or the Entner–
Doudoroff pathway during intracellular growth.
Phenotypic analysis of the DpfkAB mutant
The carbon assimilation profile of the DpfkAB mutant was
phenotypically characterized using the Biolog phenotypic
array. This analysis confirmed that the DpfkAB mutant was
unable to assimilate carbon sources that would normally be
metabolized through glycolysis, e.g. D-glucose, D-mannose,
N-acetyl-glucosamine, trehalose (data not shown). The
phagosome is also known to be a stressful environment and
it is possible that the growth defect of the DpfkAB mutant is
as a result of increased sensitivity to one (or all) of the
stresses encountered in this niche. However, analysis, using
both Biolog phenotypic arrays and other independent
assays, revealed that the DpfkAB mutant does not appear to
be more sensitive to phagosome-relevant stresses, such as
exposure to acidic pH (pH 5.5), reactive oxygen species
(H2O2) and reactive nitrogen species (acidified sodium
nitrite), than the wild-type (data not shown).
Phagosome is limiting in nucleotides
We wanted to identify additional nutritional requirements
of HM605 during growth in the macrophage. To do this we
firstly identified HM605 auxotrophic mutants by screening
a transposon mutant library for cells that were unable to
grow on M9 minimal medium agar plates with glucose as
the sole carbon source. In total 28 mutants (out of 5513
screened) were isolated and subjected to arbitrarily-primed
PCR, resulting in the identification of independent inser-
tions in 20 genes (see Table S1). Some of the identified
genes encode proteins in the same metabolic pathway (e.g.
ilvE and ilvD are both involved in the biosynthesis of isoleu-
cine, leucine and valine). Therefore, 12 mutants,
representing unique interrupted metabolic pathways, were
chosen for further analysis: purM (purine biosynthesis),
pyrF (pyrimidine biosynthesis), argB (arginine/ornithine
biosynthesis), aroC (shikimate pathway, biosynthesis of aro-
matic amino acids), trpB (tryptophan biosynthesis), proB
(proline biosynthesis), metB (methionine biosynthesis), ilvE
(isoleucine/leucine/valine biosynthesis), panC (biosynthesis
of pantothenate), cysG (siroheme biosynthesis), pdxB [pyri-
doxine 5-phosphate (vitamin B6) biosynthesis] and nadC
(NAD biosynthesis). Where possible the nature of the aux-
otrophy in each of these mutants was confirmed by supple-
menting the growth medium with the required nutrient
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Fig. 2. Glycolysis is required for intramacrophagic replication of
HM605. (a) J774A.1 macrophages were infected with HM605
and different metabolic mutants at an m.o.i. of 10 and the numbers
of intracellular bacteria were measured 6 h after the addition of
gentamicin (T6). The data are presented as percentage c.f.u. ml
 1
relative to HM605-infected macrophages. (b) Complementation of
the DpfkAB mutation by the in trans expression of pfkA or pfkB.
Statistical significance was determined using one-way ANOVA
(with Dunnett’s post-test correction for multiple comparisons);
*P<0.05, **P<0.01, ***P<0.001, ****P<0.0001.
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(see Fig. S7). The mutants were then tested for their ability
to replicate inside J774A.1 macrophages, using the gentami-
cin protection assay. The purM and pyrF mutants were
defective in intracellular growth compared to HM605 sug-
gesting that nucleotides are not available in sufficient quan-
tities to support normal growth of HM605 in the
phagosome (Fig. 3a). Moreover, we have confirmed that
growth of the pyrF mutant is complemented by the expres-
sion of the pyrF gene from a plasmid (Fig. 3b). However,
the remaining auxotrophic mutants were able to grow in
macrophages to a level that was similar to WT (Fig. 3a).
Therefore, whilst nucleotides appear to be limiting, HM605
does appear to have access to sufficient concentrations of a
wide variety of amino acids and other growth factors during
growth in the phagosome.
Pyrimidine biosynthesis intermediates
accumulate in macrophages infected with the
DpyrF mutant
To examine whether the DpyrF mutant was experiencing
pyrimidine auxotrophy during growth in the macrophage
we undertook a metabolomic analysis of infected macro-
phages. J774A.1 macrophage cells were infected with the
WT, DpyrF or DpfkAB mutant and, 6 h post-gentamicin
addition, we lysed the macrophages and analysed the intra-
cellular metabolites using liquid chromatography–mass
spectrometry (LC-MS). The pyrF gene encodes orotidine-5-
phosphate decarboxylase, an enzyme involved in the last
essential step in de novo pyrimidine biosynthesis, i.e. the
conversion of orotidine-5¢-phosphate (OMP) to UMP (see
Fig. 4a). Both the bacteria and the macrophage can synthe-
size pyrimidines and we could detect all pyrimidine biosyn-
thetic intermediates in the uninfected macrophage, with the
exception of OMP (Fig. 4a). However, a metabolite with the
same predicted mass and retention time as OMP is clearly
accumulating in macrophages infected with the DpyrF
mutant (Fig. 4a). Indeed, we could detect a significant accu-
mulation of all pyrimidine biosynthesis intermediates in
macrophages infected with the DpyrF mutant compared to
uninfected macrophages or macrophages infected with
either WT or the DpfkAB mutant, indicative of a block in
pyrimidine biosynthesis in this mutant (Fig. 4a). Therefore,
the DpyrF mutant is unable to synthesize pyrimidines in the
macrophage.
Although we were measuring the total metabolite pool from
both the bacteria and the macrophage, it is possible to annotate
bacteria-specific metabolites in our metabolomic datasets.
N2Succinyl-L-arginine (HRMSlib
1 ) is a bacteria-specific metabo-
lite produced by arginine succinyltransferase, an enzyme
encoded by astA. This is the first step in arginine degradation
via the arginine succinyltransferase (AST) pathway. S-D-Ribo-
syl-L-homocysteine (HRMSlib
1 ) is generated by the cleavage
of S-adenosyl-L-homocysteine by the 5¢-methylthioadeno-
sine/S-adenosylhomocysteine nucleosidase enzyme (encoded
bymtn) during the regeneration of S-adenosylmethionine. S-D-
Ribosyl-L-homocysteine is subsequently cleaved by the product
of the luxS gene, resulting in the production of AI-2, a quorum
sensing signalling molecule. As expected, neither N2-succinyl-
L-arginine nor S-D-ribosyl-L-homocysteine could be detected in
uninfected macrophages (Fig. 4b). However, we could detect
both metabolites in cell extracts from macrophages infected
with either WT or pyrF bacteria, implying that these bacteria
are metabolically active in the macrophage. Interestingly N2-
succinyl-L-arginine is not produced whenHM605 is cultured in
DMEM, suggesting that arginine degradation is specifically
induced in the macrophage (data not shown). It should also be
noted that there was a significantly lower level of S-D-ribosyl-L-
homocysteine in the DpyrF mutant compared to WT, suggest-
ing that pyrimidine biosynthesis is not the only metabolic
defect in this mutant. Interestingly we could not detect either of
these metabolites in macrophages infected with the DpfkAB
mutant, suggesting that this mutant has a more complete block
inmetabolism (see Fig. 4b and Fig. S8). Therefore, ourmetabo-
lomics analysis suggests that the DpyrFmutant is unable to rep-
licate due to a block in pyrimidine biosynthesis in the
macrophage. However, it does appear that the DpyrFmutant is
metabolically active, albeit to a lesser extent than theWT.
Tacrophage response to infection is not affected
by replication of HM605
We wanted to know if the ability of AIEC to replicate inside
macrophages might alter the normal macrophage response to
E. coli and, for example, contribute to the inflammation associ-
ated with CD. In this instance AIEC replication might be useful
as a therapeutic target for the treatment of some cases of CD.
Therefore, we compared the transcriptional response ofmacro-
phages infected with either HM605, the DpfkABmutant or the
non-pathogenic strain, MG1655. We selected the DpfkAB
mutant as our previous analyses had suggested that this mutant
was severely crippled in its ability to replicate in the macro-
phage (see Fig. 2). Macrophages were incubated with bacteria
in the usual way and total RNA was isolated 6 h after the addi-
tion of gentamicin. Analysis of the resulting transcriptional pro-
files revealed that there was no significant difference in the
transcriptional response of the macrophage to infection with
either HM605, the DpfkAB mutant or MG1655 (see Fig. S9).
Therefore, HM605 does not produce a protein (or any other
factor) that interferes with the normal macrophage response to
E. coli, at least not under the conditions tested here. The Gram-
negative cell-wall contains LPS, an important MAMP
(microbe-associated molecular pattern) that is recognized by
TLR4, a membrane-localized signalling protein that controls
the activity of important transcriptional regulators such as NF-
kB. Not surprisinglymany of themacrophage genes that exhib-
ited the largest increase in expression in our experiments are
known to be NF-kB regulated, e.g. Tnf, Il6 and Il12a, encoding
the important cytokines TNF-a, IL-6 and IL-12, respectively
(Fig. 5a). To confirm the increase in transcription wemeasured
the levels of TNF-a, IL-6 and IL-12 produced from infected
macrophages at T6 and we observed that the levels of these
cytokines were very similar regardless of which bacteria infected
the macrophage (Fig. 5b). Macrophages also respond to infec-
tion through the production of nitric oxide (NO) by inducible
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nitric oxide synthase, encoded by NOS2. Both WT and the
DpfkABmutant bacteria induced similar levels of expression of
NOS2 and we could also detect equivalent levels of a metabolite
annotated as N-!-hydroxyarginine (HRMSlib
1 ) in macrophages
infected with either WT or the DpfkABmutant (Fig. 5c). N-!-
Hydroxyarginine is an intermediate in the production of NO
from arginine. Therefore, our data suggest that AIEC replica-
tion does not alter the response of themacrophage to infection.
DISCUSSION
In this study we have shown that AIEC strain HM605 co-local-
izes with acidified vacuoles in the macrophage. This high level
of co-localization strongly suggests that bacterial replication is
also occurring in this niche. The nature of these vacuoles
remains to be fully determined but it is likely that they are
phagosomes. Preliminary work in our laboratory indicates that
HM605 is initially taken up into EEA1-containing vacuoles
and it has been reported previously that AIEC replicates in
LAMP1-positive vacuoles that have been identified as phago-
somes (Bringer et al., 2006; Lapaquette et al., 2012; our unpub-
lished data). We have also shown that treatment of J774A.1
macrophages with bafilomycin A or NH4Cl (compounds
known to interfere with phagosomal maturation and/or acidi-
fication) completely blocks the intramacrophagic replication
of HM605. Therefore acidification of the phagosome appears
to be a requirement for AIEC replication, an observation that
has also been published elsewhere for a different strain of
AIEC (Bringer et al., 2006; Subramanian et al., 2008). Several
intracellular pathogens are known to establish their replicative
niche within acidified vacuoles derived from the phagosome.
For example Coxiella burnetii, the causative agent of Q fever,
establishes a niche in an acidified, parasitophorous vacuole
that develops through interactions between early phagosomes
and the autophagic machinery (Voth & Heinzen, 2007). A
Type IV secretion system has been implicated in the control of
these trafficking events (Beare et al., 2011; Winchell et al.,
2014). Similarly Salmonella enterica replicates in a modified
phagosome called the Salmonella-containing vacuole (SCV)
and acidification of this phagosome is necessary as a signal for
the appropriate transcriptional response of Salmonella (includ-
ing the expression of S. enterica virulence factors) (Arpaia
et al., 2011; Thompson et al., 2011). Klebsiella pneumoniae and
Brucella suis are additional bacterial pathogens for which acidi-
fication of the phagosome has been shown to be required for
bacterial survival within macrophages (Cano et al., 2015; Porte
et al., 1999). Both Coxiella and Salmonella secrete effector pro-
teins to control the development of their replicative niches and
the capsule of K. pneumoniae has been shown to be required
to prevent lysosomal fusion with the acidified phagosome
(Cano et al., 2015). However our data suggest that AIEC strain
HM605 does not modify the normal macrophage response to
infection. Moreover comparative analysis of several AIEC
genomes has failed to identify any AIEC-specific genes that
would explain the ability of this group of bacteria to replicate
in the macrophage. Therefore the molecular details underpin-
ning the interaction between AIEC and the phagosome, and
the reasons underlying the requirement of phagosomal acidifi-
cation for replication are not yet understood.
The streptomycin mouse model has been used to show that
a number of central metabolic pathways, e.g. the Entner–
Doudoroff pathway and glycolysis are required for E. coli
colonization of the mouse gut (Chang et al., 2004). Indeed
different strains of E. coli appear to have different metabolic
requirements for colonization, and E. coli strains with simi-
lar metabolic requirements appear to compete to occupy the
same niche in the gut of the host (i.e. the restaurant hypoth-
esis) (Conway & Cohen, 2015; Maltby et al., 2013). Previous
work has also shown that gluconeogenesis and the TCA
cycle are important for the growth of uropathogenic E. coli
(UPEC) in urine (Alteri et al., 2009). We have analysed the
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Fig. 3. Purine and pyrimidine biosynthesis is required for intrama-
crophagic replication of HM605. (a) J774A.1 macrophages were
infected with HM605 and different metabolic mutants at an m.o.i.
of 10 and the numbers of intracellular bacteria were measured 6 h
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ability of a number of metabolic mutants in AIEC to repli-
cate in macrophages and we have shown that glycolysis has
a significant role during growth in the acidified phagosomal
niche. This is similar to what has recently been reported for
S. enterica serovar Typhimurium where the same mutation
(DpfkAB) prevented intracellular replication of S. Typhimu-
rium in murine RAW264.7 macrophages (Bowden et al.,
2009). The DpfkAB mutant in Salmonella was also attenu-
ated in virulence and this mutant showed significantly less
colonization of BALB/c mice after either intravenous or
intraperitoneal injection (Bowden et al., 2009; Paterson
et al., 2009). Glycolysis has also been shown to be required
for the replication of Shigella within the cytoplasm of
infected epithelial cells (Waligora et al., 2014). In AIEC, gly-
colysis appears to be the most important metabolic pathway
as mutations in the other major central metabolic pathways
involved in carbon assimilation (the TCA cycle, the pentose-
phosphate pathway and the Entner–Doudoroff pathway)
had much smaller effects on bacterial replication in the mac-
rophage (see Fig. 2). In contrast mutations in the TCA cycle
actually increased the ability of Salmonella to survive within
macrophages (Bowden et al., 2010). Therefore, whilst there
are clearly similarities in the intracellular metabolic require-
ments of E. coli and Salmonella there also appear to be sig-
nificant differences (Eisenreich et al., 2010; Götz et al.,
2010).
Our analysis of auxotrophic mutants in HM605 suggests
that the phagosome is relatively rich in amino acids and
other nutrients. Indeed, none of the amino acid auxotrophs
exhibited a significant decrease in replication, suggesting
that these nutrients are available in adequate amounts in
the phagosome. This is in agreement with a previous study
that analysed S. Typhimurium gene expression during repli-
cation in the macrophage and concluded that the SCV is
rich in amino acids (Eriksson et al., 2003). However, our
study did reveal a requirement for de novo purine and
pyrimidine biosynthesis during the intramacrophagic repli-
cation of HM605. Therefore, mutations in either purM or
pyrF were significantly affected in their ability to replicate in
the macrophage (see Fig. 3). The pyrF gene encodes the
enzyme required for the conversion of OMP to UMP and
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metabolomics has confirmed that OMP accumulates in
macrophages infected with the DpyrF mutant. Therefore,
the DpyrF mutant is blocked in pyrimidine biosynthesis and
appears to be experiencing pyrimidine auxotrophy in the
macrophage. Interestingly, a DpyrF mutant in Francisella
tularenis has been shown to be unable to replicate in the
cytosol of infected macrophages, suggesting that sufficient
levels of pyrimidines are limiting throughout the macro-
phage and not just in the phagosome (Horzempa et al.,
2010). The purM gene encodes an enzyme that catalyses the
fifth step in the de novo biosynthesis of purines. Whilst there
are no reports of any requirement for purine biosynthesis
during bacterial intramacrophagic replication, it has been
shown that purine biosynthesis-deficient mutants of Bur-
kholderia, Sinorhizobium and Photorhabdus are defective in
their ability to form symbiotic associations with insects,
plants and nematodes, respectively (Ruisheng & Grewal,
2011; Buendía-Clavería et al., 2003; Kim et al., 2014). More-
over Pseudomonas aeruginosa must synthesize purines dur-
ing both chronic and acute infections of animals (Turner
et al., 2014). Therefore the availability of purines would
appear to be limiting in the host. Finally, although it was
not deemed to be significant (P=0.086), there was an
approximately 50% reduction in the intramacrophagic
growth of the argB mutant, suggesting that arginine levels
may affect bacterial replication in the macrophage (see
Fig. 3a). The reduced growth of the argB mutant may be a
bona fide requirement for arginine, or the phenotype may
be a consequence of the regulatory and metabolic links
between arginine biosynthesis and both purine and pyrimi-
dine biosynthesis (Caldara et al., 2008; Cho et al., 2011).
Indeed we favour the latter as HM605 assimilates arginine
during replication in the macrophage, suggesting that argi-
nine is not limiting in this niche (see Fig. 4).
Recent work has implicated AIEC in the pathophysiology of
CD and it has been shown that J774A.1 macrophages
infected with AIEC strain LF82 produced up to three times
more TNF-a compared with macrophages stimulated with
LPS alone, and the production of TNF-a was dependent on
the numbers and/or replication of LF82 in the macrophage
(Bringer et al., 2012; Glasser et al., 2001). We have shown
that J774A.1 macrophages infected with AIEC strain
HM605 produce similar levels of TNF-a (and other cyto-
kines) compared with macrophages infected with a non-
pathogenic strain of E. coli, and we have shown that the
production of TNF-a is similar regardless of whether the
macrophage is infected with HM605 or a non-replicating
mutant (see Fig. 5). Therefore it appears that the relation-
ship between AIEC and the production of cytokines by
macrophages may be strain-dependent, implying that dif-
ferent strains of AIEC may contribute to inflammation in
different ways. This further highlights the heterogeneous
nature of this group of E. coli.
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